Skip to main content
OpenTrials

Clinical trial condition

Hepatorenal Syndrome

Explore clinical trials studying Hepatorenal Syndrome. Study availability and eligibility vary by location and protocol.

30 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Hepatorenal Syndrome trial results

Completed

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

NCT04460560

Conditions
Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • Piedmont Healthcare, Inc Atlanta, Georgia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

NCT05387811

Conditions
Acute Kidney Injury, Digestive System Diseases, Female Urogenital Diseases, +12 more
Locations
  • Indiana University Indianapolis, Indiana, United States
  • Ochsner Medical Center New Orleans, Louisiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Baylor University Medical Center Dallas, Texas, United States
View all 38 locations
View Trial Details
Completed

A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

NCT05309200

Conditions
Acute Kidney Injury, Ascites, Cirrhosis, +13 more
Locations
  • Mayo Clinic - Phoenix Phoenix, Arizona, United States
  • Keck Medical Center of USC Los Angeles, California, United States
  • University of California, San Francisco Liver Clinic San Francisco, California, United States
  • Stanford Hospital Stanford, California, United States
View all 23 locations
View Trial Details
Completed

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

NCT02770716

Conditions
Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner Good Samaritan Medical Center Phoenix, Arizona, United States
  • Mayo Clinic - AZ Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
View all 64 locations
View Trial Details
Completed

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

NCT01143246

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Ascites, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner Good Samaritan Medical Center/Liver Disease Center Phoenix, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of Arizona Medical Center South Campus Tucson, Arizona, United States
View all 73 locations
View Trial Details

Related conditions